Dragan Cicic, M.D.
About Dragan Cicic, M.D.
Dragan Cicic, M.D., is a seasoned biopharmaceutical executive with over 20 years of experience, currently serving as the Senior Vice President and Chief Development Officer.
Dragan Cicic, M.D. Company Title
Dragan Cicic, M.D. currently serves as the Senior Vice President and Chief Development Officer. He plays a crucial role in shaping the strategic direction of his organization and is responsible for overseeing various development initiatives within the company.
Dragan Cicic, M.D. Education and Expertise
Dragan Cicic holds an MBA from the Wharton School of the University of Pennsylvania, one of the top business schools globally. He completed a Fellowship at Harvard University, enhancing his medical and research expertise. Additionally, he earned his medical degree from the University of Belgrade, laying the foundation for his extensive career in the biopharmaceutical industry.
Dragan Cicic, M.D. Professional Background
With over two decades of experience in the biopharmaceutical industry, Dragan Cicic has held senior management positions at various organizations. He was previously part of Actinium Pharmaceuticals in a senior management role. At Klus Pharma, he served as Senior Vice President, Clinical Lead, demonstrating his leadership in clinical operations and research.
Dragan Cicic, M.D. Publications and Research
Dragan Cicic has published extensively in the fields of hematologic malignancies and solid cancers. His contributions to medical literature have provided valuable insights and advancements in these areas, reflecting his deep commitment to research and improving patient outcomes.
Dragan Cicic, M.D. Professional Affiliations
Dragan Cicic is a member of the American Society of Hematology (ASH). His affiliation with this prestigious organization underscores his professional dedication and involvement in the field of hematology.